Skip to content
Trial Eligibility
Menu

Nomad P-KAFO Study

NCT05644522

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to evaluate the impact of using the Nomad powered KAFO in people who have had a musculoskeletal or neurological injury that has affected their ability to walk. The main questions it aims to answer are to quantify the effectiveness of the Nomad in improving mobility, balance, frequency of falls, and quality of life in individuals with lower-extremity impairments compared to their own brace, over three months of daily home and community use. Participants will: Wear a sensor that records everyday activities and mobility.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Cerebrovascular Accident
  • Post-polio Syndrome
  • Spinal Cord Injuries
  • Multiple Sclerosis
  • Muscular Dystrophy
  • Paralysis

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 89 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Shirley Ryan AbilityLab
Last updated on ClinicalTrials.gov
May 11, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Shirley Ryan AbilityLab · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.